Literature DB >> 6864906

Prognostic indicators in renal adenocarcinoma.

J M Siminovitch, J E Montie, R A Straffon.   

Abstract

From 1968 to 1978, 246 patients underwent surgical exploration for renal adenocarcinoma at our clinic. Of these patients 241 had complete tumor excision and 5 had biopsy only. Correlation of the clinical and pathological data of these patients with the clinical course identified prognostic parameters. Disease progression was uncommon when the tumor was contained within the capsule of the kidney (9 of 80 patients). Perinephric tumor extension indicated a worse prognosis (11 of 40 patients with progression) that was not altered significantly by the presence of renal vein involvement (17 of 35 patients with progression). Inferior vena caval involvement or regional lymph node metastases worsened the prognosis markedly, with 8 of 11 and 8 of 9 patients demonstrating progressive disease, respectively. The worst prognosis was seen in patients with metastatic disease at operation (66 of the 71 patients dying of the disease by the end of followup). The disease was classified according to the tumor, node and metastasis system of the American Joint Committee and a stage grouping system has been suggested.

Entities:  

Mesh:

Year:  1983        PMID: 6864906     DOI: 10.1016/s0022-5347(17)50933-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

Review 1.  The Role of Lymph Node Dissection for Non-Metastatic Renal Cell Carcinoma: An Updated Systematic Review and Meta-Analysis.

Authors:  Xu Shi; Dechao Feng; Dengxiong Li; Facai Zhang; Wuran Wei
Journal:  Front Oncol       Date:  2022-01-12       Impact factor: 6.244

2.  [Renal cell carcinoma. Comparative analysis of the prognostic significance of the WHO-classification and the Störkel's prognostic score].

Authors:  S Gunia; M May; K Korb; P Stosiek
Journal:  Urologe A       Date:  2004-04       Impact factor: 0.639

3.  Adjuvant chemotherapy with vinblastine, adriamycin, and UFT for renal-cell carcinoma.

Authors:  F Masuda; J Nakada; I Kondo; N Furuta
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Surgical treatment of renal cell carcinoma metastases: prognostic significance.

Authors:  M Takashi; Y Takagi; T Sakata; T Shimoji; K Miyake
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

5.  Prognostic significance of perirenal infiltration in renal cell carcinoma (<7 cm).

Authors:  Seongyub Oh; Jangho Yoon; Dongil Kang; Heung Lae Cho; Jae-il Chung
Journal:  Yonsei Med J       Date:  2012-09       Impact factor: 2.759

6.  Multivariate evaluation of prognostic determinants for renal cell carcinomas which are metastatic at initial diagnosis.

Authors:  M Takashi; T Kawai; T Murase; K Wakai; Y Ohno
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

7.  Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.

Authors:  Chiara Mignogna; Stefania Staibano; Vincenzo Altieri; Gaetano De Rosa; Giuseppe Pannone; Angela Santoro; Rosanna Zamparese; Massimino D'Armiento; Romualdo Rocchetti; Ernesto Mezza; Mario Nasti; Viviana Strazzullo; Vittorino Montanaro; Massimo Mascolo; Pantaleo Bufo
Journal:  BMC Cancer       Date:  2006-12-19       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.